<

Biodesix Secures $6,114,729 New Funding Round

  • Feed Type
  • Date
    7/28/2016
  • Company Name
    Biodesix
  • Mailing Address
    2970 Wilderness Place Boulder, CO 80301 USA
  • Company Description
    Biodesix makes blood-based diagnostic tests that help guide treatment of patients with advanced cancer. Our test results are available within 72 hours.
  • Website
    http://www.biodesix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,114,729
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 15 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy